02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 44.48
−1.29%Forward multiples
Based on analyst estimates
- P/E forward
- 51.09x
- P/E 2026E
- 26.68x
- P/E 2027E
- 21.47x
- P/E 2028E
- 17.54x
- P/S forward
- 10.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.26x
- PEG TTM
- 1.44x
- Price / book
- 3.17x
- Price / sales
- 6.45x
- Price / cash flow
- 16.83x
Enterprise value
- Enterprise value
- HKD 174.6B
- EV / sales
- 6.29x
- EV / EBITDA
- 15.67x
- EV / EBIT
- 19.43x
- Market cap
- HKD 179.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026